Lineage of measurable residual disease in patients with chronic myeloid leukemia in treatment-free remissionIlaria S. Pagani, David M. Ross, Naranie Shanmuganathan et al.|Leukemia|2019Cited by 51
TGF-α and IL-6 plasma levels selectively identify CML patients who fail to achieve an early molecular response or progress in the first year of therapyEva Nievergall, Deborah L. White, John Reynolds et al.|Leukemia|2016Cited by 50